Thursday, February 01, 2007 9:59:41 AM
Hollis-Eden Pharmaceuticals Provides Update on Negotiations for BioShield Procurement Contract for NEUMUNE(R) as a Treatment for Acute Radiation Syndrome
Thursday February 1, 7:00 am ET
SAN DIEGO--(BUSINESS WIRE)--Hollis-Eden Pharmaceuticals, Inc. (Nasdaq:HEPH - News) today provided an update on its progress in negotiations with the Department of Health and Human Services (HHS) on a potential BioShield procurement contract for NEUMUNE®, the Company's lead drug candidate for Acute Radiation Syndrome (ARS). On January 31, 2007, Hollis-Eden received notice from HHS that the agency is still in the process of evaluating the Company's revised proposal and that, in order to allow the government the time needed to complete its evaluation, HHS has revised its estimated planned contract award date to March 7, 2007.
Recent HRBR News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 09:51:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:35:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/15/2023 02:48:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 09:04:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:36:23 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM